1028258-40-3

Basic information

• Product Name: (S)-2-((tert-butoxycarbonyl)amino)-4-(phenylselanyl)butanoic acid
• Synonyms: (S)-2-((tert-butoxycarbonyl)amino)-4-(phenylselanyl)butanoic acid
• CAS NO: 1028258-40-3
• Molecular Weight: 358.296
• Mol File: 1028258-40-3.mol

Chemical Properties

• CAS DataBase Reference: (S)-2-((tert-butoxycarbonyl)amino)-4-(phenylselanyl)butanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-((tert-butoxycarbonyl)amino)-4-(phenylselanyl)butanoic acid(1028258-40-3)
• EPA Substance Registry System: (S)-2-((tert-butoxycarbonyl)amino)-4-(phenylselanyl)butanoic acid(1028258-40-3)

Safety Data

• Hazardous Substances Data: 1028258-40-3(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1666-13-3 diphenyl diselenide 
• 40856-59-5 tert-butyl (3S)-2-oxotetrahydrofuran-3-ylcarbamate 

Downstream Products

• 1241032-65-4 C₂₆H₃₉N₃O₄Se 
• 104523-58-2 (S)-benzyl 2-((tert-butoxycarbonyl)amino)but-3-enoate 
• 104523-59-3 (S)-benzyl 2-((tert-butoxycarbonyl)amino)-4-(phenylselanyl)butanoate 
• 1163728-28-6 tert-butyl {(1S)-[(1S)-{(5R)-but-3-enylcarbamoyl-2,2-dimethyl-[1,3]dioxolan-(4S)-yl}-2-methylpropylcarbamoyl]-3-phenylselenylpropyl}carbamate 
• 174655-65-3 diphenylmethyl N-(tert-butoxycarbonyl)-2-vinylglycinate 
• 174655-64-2 diphenylmethyl N-(tert-butoxycarbonyl)-2-<2'-(phenylseleno)ethyl>glycinate 

Relevant articles and documents

The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivity

The preparation of a Syringolin A/Glidobactin A hybrid (SylA-GlbA) consisting of a SylA macrocycle connected to the GlbA side chain and its potent proteasome targeting of all three proteasomal subsites is reported. The influence of the syrbactin macrocycle moiety on subsite selectivity is demonstrated.

DEVELOPMENT OF A SYNTHESIS OF SYRINGOLIN A AND B AND DERIVATIVES THEREOF

The synthesis of syringolin A and B and derivatives thereof as well as to pharmaceutical compositions containing the syringolin A or B or derivatives thereof and the use of syringolin A and B and derivatives thereof for prophylaxis and treatment of cancer.

A convenient synthesis of L-α-vinylglycine from L-homoserine lactone

A procedure for the synthesis of L-α-vinylglycine from L-homoserine lactone is described. The route developed is convenient (only one chromatography step is required) and efficient (72%; ≥95% optical yield over 4 steps). Key features include the use of acid-labile protecting groups for the amino (Boc) and carboxyl (diphenylmethyl ester) groups, and the use of the phenylselenolate equivalent derived from sodium borohydride and diphenyl diselenide for L-homoserine lactone cleavage.